Designing a ligand for pharmaceutical purposes.


BACKGROUND Drug approval applications to the FDA have shown a remarkably small increment compared with what was expected. In the last few years several efforts have been made to improve the results of rational drug design approaches and in particular to predict inhibitor-target structure and to evaluate the free energy of binding. Virtual database screening… (More)
DOI: 10.1517/17460441.3.5.579


4 Figures and Tables

Slides referencing similar topics